2'-Fluoro-c-di-GMP as an oral vaccine adjuvant
- PMID: 35541605
- PMCID: PMC9076492
- DOI: 10.1039/c9ra08310c
2'-Fluoro-c-di-GMP as an oral vaccine adjuvant
Abstract
Bis-(3'-5')-cyclic dimeric 2'-deoxy-2'-fluoroguanosine monophosphate (2'-F-c-di-GMP) was synthesized through the modified H-phosphonate chemistry. Oral immunization of C57BL/6 mice with Helicobacter pylori cell-free sonicate extract adjuvanted with 2'-F-c-di-GMP led to the production of antigen-specific antibodies in feces and sera, and lowered bacterial counts in the stomach upon post-vaccination infections in immunized mice. Similarly, oral vaccination of BALB/c mice with flagillin proteins from Clostridium difficile and Listeria monocytogenes adjuvanted with 2'-F-c-di-GMP led to production of antigen-specific antibodies both systemically and mucosally. The adjuvanticity of 2'-F-c-di-GMP is associated with the enhanced induction of interferon γ. These results demonstrated the excellent oral adjuvanticity of 2'-F-c-di-GMP.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
Work described in this manuscript is partially disclosed in WO patent 2015/074145A1 and US patent 10092644.
Figures






Similar articles
-
Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against Bordetella pertussis in a Mouse Model.Front Immunol. 2022 Apr 13;13:878832. doi: 10.3389/fimmu.2022.878832. eCollection 2022. Front Immunol. 2022. PMID: 35493458 Free PMC article.
-
A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.Vaccine. 2014 May 30;32(26):3216-22. doi: 10.1016/j.vaccine.2014.04.011. Epub 2014 Apr 13. Vaccine. 2014. PMID: 24731807
-
Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice.Vaccine. 2011 Jul 12;29(31):4973-82. doi: 10.1016/j.vaccine.2011.04.094. Epub 2011 May 18. Vaccine. 2011. PMID: 21600260
-
Cyclic-di-GMP signaling in the Gram-positive pathogen Clostridium difficile.Curr Genet. 2015 Nov;61(4):497-502. doi: 10.1007/s00294-015-0484-z. Epub 2015 Mar 24. Curr Genet. 2015. PMID: 25800812 Review.
-
The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.Vaccine. 2010 Apr 19;28(18):3080-5. doi: 10.1016/j.vaccine.2010.02.081. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20197136 Review.
Cited by
-
The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development.Vaccines (Basel). 2021 Aug 17;9(8):917. doi: 10.3390/vaccines9080917. Vaccines (Basel). 2021. PMID: 34452042 Free PMC article. Review.
-
How Long Will It Take to Launch an Effective Helicobacter pylori Vaccine for Humans?Infect Drug Resist. 2023 Jun 15;16:3787-3805. doi: 10.2147/IDR.S412361. eCollection 2023. Infect Drug Resist. 2023. PMID: 37342435 Free PMC article. Review.
-
Parenteral immunization with a cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) adjuvanted Helicobacter pylori vaccine induces protective immunity against H. pylori infection in mice.Hum Vaccin Immunother. 2020 Nov 1;16(11):2849-2854. doi: 10.1080/21645515.2020.1744364. Epub 2020 Apr 16. Hum Vaccin Immunother. 2020. PMID: 32298215 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous